Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis
Objectives To assess the risk of new-onset or worsening hyperglycaemia, hypertension, weight gain and hyperlipidaemia with systemic corticosteroid therapy (CST) as reported in published randomised control trial (RCT) studies.Data sources Literature search using MEDLINE, EMBASE, Cochrane library, Web...
| 出版年: | BMJ Open |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMJ Publishing Group
2022-12-01
|
| オンライン・アクセス: | https://bmjopen.bmj.com/content/12/12/e061476.full |
